Stock UniverseDerived research view · source repositories remain read-only

Evolus, Inc. (EOLS)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Speculative
Selection Score
23.45
Global Rank
2979
Market Cap
278.73M
Latest Close
6.67
RS Composite
2.47% · G#1169

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
5.54%
3M
20.61%
6M
-1.19%
1Y
-31.94%
3Y
-26.30%
5Y
-38.35%
10Y
-42.00%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 670.70K · 30-day average: 889.45K · Max drawdown over stored range: -92.41%

Research Snapshot

Relative Strength vs SPX

RS Composite2.47%
20D RS3.75%
60D RS14.78%
120D RS-10.47%
Global RS Rank1169 · 65.16% percentile
Watch+Speculative RS Rank748 · 64.33% percentile
Group ScopeWatch+Speculative
Primary RS Rank123 · 73.14% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank359 / 701
Primary Percentile48.93
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for EOLS.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue56.5499.673148.616202.085266.274297.176
Revenue Growth (YoY)61.89%76.288%49.104%35.978%31.763%11.605%
Gross Profit38.24156.13989.774137.571182.304
Operating Income-68.698-63.615-57.575-36.107-27.235
Free Cash Flow-58.686-33.781-86.53-34.481-19.471-45.706
Free Cash Flow Per Share-1.739-0.679-1.543-0.606-0.314-0.7089618526684326
EPS (Diluted) GAAP-4.831755-0.940467-1.327238-1.083738-0.813004
EPS Growth
EPS Non-GAAP
Gross Margin67.635%56.323%60.407%68.076%68.465%66.3267%
Operating Margin-121.503%-63.824%-38.741%-17.867%-10.228%-10.9908%
Profit Margin-288.314%-46.964%-50.07%-30.524%-18.935%-17.3772%
Free Cash Flow Margin-103.796%-33.892%-58.224%-17.063%-7.312%-15.3801%
Shares Outstanding (Diluted)33.737849.773156.065356.918762.016964.4689
Shares Change (YoY)19.478%47.529%12.642%1.522%8.957%3.954%

SEC Quarterly Fundamentals

No processed quarterly rows for EOLS.